Imminent CVS-Aetna Deal Sparks Antitrust Concerns

Imminent CVS-Aetna Deal Sparks Antitrust Concerns
AP Photo/Matt Rourke, File

With a $66 billion deal between Aetna and CVS reportedly imminent, more questions are emerging about whether the acquisition will survive regulatory scrutiny.

Citing people familiar with the matter, The Wall Street Journal reported that a tie-up between CVS and Aetna could be announced as early as Monday, as the two companies are in advanced stages of negotiation.

The deal would combine one of the country's largest health insurers with a company that is not only a retail and pharmacy giant but also one of the biggest pharmacy benefit managers.



Comment
Show comments Hide Comments


Related Articles